Monday, October 27, 2008

Leukemia drug may stop progression of MS symptoms

From CTV News:
There is new hope for patients who suffer from multiple sclerosis, as a drug initially developed to treat a form of leukemia may stop the progression of the debilitating neurological disease.

Researchers from the University of Cambridge have found that alemtuzumab not only halts the advancement of multiple sclerosis (MS), but it may also restore some function lost by patients.

MS is an autoimmune disease that causes the immune system to attack the insulation that covers nerve fibres in the central nervous system.

This causes the nerves to malfunction and then die off, which results in a number of physical and intellectual disabilities.

In the study, the drug reduced the risk of developing disabilities by 71 per cent compared to the common drug treatment for MS, interferon beta-1a. ...more

No comments: